Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine"
DOI: 10.1007/s12020-021-02915-7
Abstract: Zollinger Ellison syndrome (ZES) is a rare syndrome caused by gastrin hypersecretion from a gastrinoma. Gastrinoma treatment has two goals: the control of acid hypersecretion and the control of tumor growth. While therapy for the… read more here.
Keywords: syndrome zes; somatostatin analogs; ssas; ellison syndrome ... See more keywords